Cargando…

Tau positron emission tomography imaging in tauopathies: The added hurdle of off-target binding

Ligands targeting tau for use with positron emission tomography have rapidly been developed during the past several years, enabling the in vivo study of tau pathology in patients with Alzheimer's disease and related non-Alzheimer's disease tauopathies. Several candidate compounds have been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lemoine, Laetitia, Leuzy, Antoine, Chiotis, Konstantinos, Rodriguez-Vieitez, Elena, Nordberg, Agneta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Special Section: State of the Field: Advances in Neuroimaging from the 2017 Alzheimer’s Imaging Consortium. (Guest Editors: Drs. David Wolk, Victor Villemagne & Bradford Dickerson)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956931/ https://www.ncbi.nlm.nih.gov/pubmed/29780868 http://dx.doi.org/10.1016/j.dadm.2018.01.007

Ejemplares similares

Topographic staging of tau positron emission tomography images
por: Schwarz, Adam J., et al.
Publicado: (2018)

Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathology
por: Gordon, Brian A., et al.
Publicado: (2018)

Regional tract-specific white matter hyperintensities are associated with patterns of aging-related brain atrophy via vascular risk factors, but also independently
por: Habes, Mohamad, et al.
Publicado: (2018)

Elevated medial temporal lobe and pervasive brain tau-PET signal in normal participants
por: Lowe, Val J., et al.
Publicado: (2018)

Similar pattern of atrophy in early- and late-onset Alzheimer's disease
por: Eckerström, Carl, et al.
Publicado: (2018)

Molecular imaging: What is right and what is an illusion?
por: Klunk, William E.
Publicado: (2018)

The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment
por: Racine, Annie M., et al.
Publicado: (2018)

Advances in Alzheimer's imaging are changing the experience of Alzheimer's disease
por: Stites, Shana D., et al.
Publicado: (2018)

Neuropsychology and neuroimaging profiles of amyloid-positive versus amyloid-negative amnestic mild cognitive impairment patients
por: Tomadesso, Clémence, et al.
Publicado: (2018)

Tau PET imaging in neurodegenerative tauopathies—still a challenge
por: Leuzy, Antoine, et al.
Publicado: (2019)

Tau PET imaging: present and future directions
por: Saint-Aubert, Laure, et al.
Publicado: (2017)

The Early Growth Genetics (EGG) and EArly Genetics and Lifecourse Epidemiology (EAGLE) consortia: design, results and future prospects
por: Middeldorp, Christel M., et al.
Publicado: (2019)

Tau PET following acute TBI: Off-target binding to blood products, tauopathy, or both?
por: Butler, Tracy, et al.
Publicado: (2022)

Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging
por: Murugan, N. Arul, et al.
Publicado: (2019)

Association between Aβ and tau accumulations and their influence on clinical features in aging and Alzheimer's disease spectrum brains: A [(11)C]PBB3-PET study
por: Shimada, Hitoshi, et al.
Publicado: (2016)

Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition
por: Vemuri, Prashanthi, et al.
Publicado: (2016)

Cognitive complaints in older adults at risk for Alzheimer's disease are associated with altered resting-state networks
por: Contreras, Joey A., et al.
Publicado: (2016)

A comparison of measurement methods of hippocampal atrophy rate for predicting Alzheimer's dementia in the Aberdeen Birth Cohort of 1936
por: Rana, Arnab K., et al.
Publicado: (2016)

The APOE ε4 genotype modulates CSF YKL-40 levels and their structural brain correlates in the continuum of Alzheimer's disease but not those of sTREM2
por: Gispert, Juan Domingo, et al.
Publicado: (2016)

Alzheimer's disease: The influence of age on clinical heterogeneity through the human brain connectome
por: Dickerson, Bradford C., et al.
Publicado: (2016)

A robust biomarker of large-scale network failure in Alzheimer's disease
por: Wiepert, Daniela A., et al.
Publicado: (2017)

Assessment of Tau Pathology as Measured by (18)F-THK5317 and (18)F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer’s Disease
por: Colato, Elisa, et al.
Publicado: (2021)

Maternal and neonatal immunization in the Americas: The benefits, the hurdles, and the way forward()
por: Pasetti, Marcela F., et al.
Publicado: (2021)

Trends in the incidence of dementia: design and methods in the Alzheimer Cohorts Consortium
por: Chibnik, Lori B., et al.
Publicado: (2017)

Scientific Integrity Principles and Best Practices: Recommendations from a Scientific Integrity Consortium
por: Kretser, Alison, et al.
Publicado: (2019)

The LifeCycle Project-EU Child Cohort Network: a federated analysis infrastructure and harmonized data of more than 250,000 children and parents
por: Jaddoe, Vincent W. V., et al.
Publicado: (2020)

Priorities for science to overcome hurdles thwarting the full promise of the ‘digital agriculture’ revolution
por: Shepherd, Mark, et al.
Publicado: (2018)

Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
por: Leuzy, Antoine, et al.
Publicado: (2019)

Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations
por: Witte, Michael M., et al.
Publicado: (2015)

Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer’s disease
por: Carter, Stephen F., et al.
Publicado: (2018)

Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography
por: Risacher, Shannon L., et al.
Publicado: (2017)

Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome population
por: Lao, Patrick J., et al.
Publicado: (2017)

Effect of apolipoprotein E phenotype on the association of plasma amyloid β and amyloid positron emission tomography imaging in Japan
por: Tateno, Amane, et al.
Publicado: (2017)

Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes
por: Weston, Philip S.J., et al.
Publicado: (2015)

Spatial Normalization of (18)F-Flutemetamol PET Images Using an Adaptive Principal-Component Template
por: Lilja, Johan, et al.
Publicado: (2019)

Regional tau deposition and subregion atrophy of medial temporal structures in early Alzheimer's disease: A combined positron emission tomography/magnetic resonance imaging study
por: Sone, Daichi, et al.
Publicado: (2017)

Magnetic resonance imaging for monitoring therapeutic response in a transgenic mouse model of Alzheimer’s disease using voxel-based analysis of amyloid plaques
por: Kim, Jae-Hun, et al.
Publicado: (2014)

Automatic Detection of Cognitive Impairments through Acoustic Analysis of Speech
por: Nagumo, Ryosuke, et al.
Publicado: (2020)

Optimal timing of tau pathology imaging and automatic extraction of a reference region using dynamic [(18)F]THK5317 PET
por: Jonasson, My, et al.
Publicado: (2019)

Clinical impact of [(18)F]flutemetamol PET among memory clinic patients with an unclear diagnosis
por: Leuzy, Antoine, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_17j8486c8voq43mmhfrfp9buki